The study was published in Proceedings of the National Academy of Sciences on March 4, 2026, and was funded by federal research grants from the National Institutes of Health (MD, USA) and private philanthropy
Patients should always discuss cyclophosphamide therapy with their doctor to make sure that the benefits outweigh the risks
Injections and IV drips carry higher cost and risk and must be given by medical professionals
Features 50mM Tris-HCl (pH7.5), 200mM NaCl, 2mM EGTA Also available are Calmodulin Resin Kits
Faderl S, Thomas DA, Garcia-Manero G, Ravandi F, Beran M, Rytting M, Koller CA, Verstovsek S, Borthakur G, Andreeff M , Kornblau S, Vu K, Jarmon R, Kantarjian HM